Table 3. Percentual component concentration of the formulations proposed for the tablet.
Component* | Formulation 1 (%) | Formulation 2 (%) | Formulation 3 (%) |
---|---|---|---|
MC 102 | 35.50 | 33.00 | 41.00 |
PVP K-30 | 2.50 | 5.00 | 1.00 |
TAL | 10.00 | 10.00 | 10.00 |
CSD | 1.00 | 1.00 | 1.00 |
CRO | 5.00 | 5.00 | 1.00 |
AMCA | 46.00 | 46.00 | 46.00 |
*MC 102: microcrystalline cellulose PH 102; PVP K-30: polyvinylpyrrolidone K-30; TAL: talc; CSD: colloidal silicone dioxide; CRO: sodium croscarmellose; AMCA: X. americana dry extract.